NeuroOne Medical Technologies Corporation (NMTC)

NASDAQ: NMTC · Real-Time Price · USD

2.030

-0.120 (-5.58%)

At close: Aug 21, 2026, 4:00 PM EDT

2.310

+0.280 (13.79%)

After-hours: Aug 21, 2026, 7:39 PM EDT

NMTC Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	18	44	31	21	27	47
Market Cap Growth	-50.84%	45.65%	43.23%	-22.25%	-42.21%	66.31%
Enterprise Value	17	37	29	18	17	39
Last Close Price	2.03	5.33	5.94	5.34	10.14	23.70

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
PS Ratio	1.48	3.67	8.83	6.25	12.92	195.11
PB Ratio	4.69	6.28	37.11	3.41	2.85	7.23
P/TBV Ratio	4.94	6.32	40.42	3.46	2.89	7.38

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
EV/Sales Ratio	1.33	3.03	8.45	5.41	8.23	159.21

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Debt / Equity Ratio	0.05	0.04	0.32	0.03	0.02	0.05
Net Debt / Equity Ratio	-0.50	-0.89	-1.46	-0.82	-1.14	-1.00
Net Debt / EBITDA Ratio	0.24	1.59	0.10	0.44	1.10	0.65
Net Debt / FCF Ratio	0.26	2.16	0.11	0.39	1.40	0.76
Asset Turnover	1.47	1.50	0.51	0.33	0.20	0.04
Inventory Turnover	4.59	3.68	3.41	6.94	12.88	-
Quick Ratio	1.54	3.40	0.74	2.97	3.61	5.88
Current Ratio	2.84	4.44	2.09	4.08	3.93	6.17
Return on Equity (ROE)	-124.66%	-91.34%	-348.39%	-149.61%	-123.77%	-230.81%
Return on Assets (ROA)	-58.07%	-32.70%	-110.33%	-71.43%	-60.39%	-100.59%
Return on Capital Employed (ROCE)	-190.60%	-49.80%	-376.60%	-189.60%	-103.20%	-151.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Earnings Yield	-40.28%	-8.12%	-40.38%	-55.68%	-36.50%	-20.99%
FCF Yield	-38.74%	-6.57%	-36.49%	-62.31%	-28.46%	-18.29%
Buyback Yield / Dilution	-44.82%	-50.03%	-47.69%	-13.27%	-49.56%	-97.52%

SEC Filings: 10-K · 10-Q